Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Aadi, AB, Amryt, BMS, Gilead, Janssen, Neonmind, RDIF, Revive, Seqirus, Sterna, Tonix.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Aligos, Astrocyte, Bluebird, Curative, Dragonfly, Evrys, Kancera, Marvel, Merck & Co., Qurient, Sellas, Simcere, Tonix, Vipergen.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Aptevo, Dnatrix, Galapagos, Ocuphire, Oncotelic, Oramed, Santhera, Scynexis, Transgene.

The Pan American Health Organization is echoing fears that the COVID-19 pandemic will result in a surge of drug-resistant infections, saying surges already are being seen in several countries in the Americas, including Argentina, Ecuador, Guatemala, Paraguay and Uruguay.

U.S. trading partners are raising concerns about the FDA’s continued delays in inspecting foreign drug manufacturing facilities due to the COVID-19 pandemic and related travel restrictions.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Algernon, Ascentage, Biomarin, Biontech, Bluebird, Carsgen, Crispr, Deciphera, GSK, Janssen, Merck & Co., Moderna, Obseva, Pfizer, Provention, Reata, Rgenix, Roche, Viiv.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Achieve, Affimed, Akston, Amring, Amzell, Apollomics, Arctic Vision, Beigene, Catapult, Concentric, Daiichi, Day One, Diffusion, Exelixis, Imara, Innovent, Intellia, Lixte, Neoimmunetech, Noxxon, Pfizer, Pulmonem, Puma, Regeneron, Syneurx, Tennor, Zealand.